An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
August 21st, 2020
8.3K views
Presented here is a protocol for a standardized in vitro hemodynamic loop model. This model allows to test the hemocompatibility of perfusion tubes or vascular stents to be in accordance with ISO (International Organization for Standardization) standard 10993-4.
Overview
This article presents a protocol for a standardized in vitro hemodynamic loop model that tests the hemocompatibility of vascular devices such as perfusion tubes and stents. The model adheres to ISO standard 10993-4, ensuring reliable results without mechanical impact on blood components.
Key Study Components
Area of Science
- Hemocompatibility testing
- Vascular device evaluation
- In vitro models
Background
- Hemocompatibility is crucial for the safety of vascular devices.
- Standardized testing protocols are necessary for regulatory compliance.
- Mechanical forces can activate blood components, leading to misleading results.
- This study aims to provide a reliable method for assessing vascular device compatibility.
Purpose of Study
- To develop a standardized in vitro hemodynamic loop model.
- To evaluate the hemocompatibility of perfusion tubes and vascular stents.
- To comply with ISO standards for testing vascular devices.
Methods Used
- Assembly of a hemodynamic loop using specific tubing and connectors.
- Collection and preparation of blood samples with heparin.
- Rotation of loops to simulate blood flow conditions.
- Analysis of blood samples using flow cytometry and imaging techniques.
Main Results
- Significant differences in blood component activation among tested devices.
- Latex loops showed poor biocompatibility with increased leukocyte activation.
- Heparin-coated PVC loops exhibited reduced activation compared to other materials.
- Flow cytometric analysis revealed variations in platelet and leukocyte responses.
Conclusions
- The hemodynamic loop model is effective for testing vascular device compatibility.
- Material choice significantly impacts hemocompatibility outcomes.
- Standardized testing can improve the safety of vascular devices.
Frequently Asked Questions
What is the purpose of the hemodynamic loop model?
The model is designed to test the hemocompatibility of vascular devices under standardized conditions.
How does the model avoid mechanical activation of blood?
The model operates without exerting mechanical forces on the blood, preventing misleading results.
What materials are used in the loop assembly?
The assembly uses specific tubing, connectors, and a tension band system to create the loop.
How is blood prepared for testing?
Blood is collected with heparin and prepared to avoid hemolysis and cell activation.
What analysis techniques are employed?
Flow cytometry and imaging techniques like scanning electron microscopy are used for analysis.
Executive Industry Relevance
This in vitro hemodynamic loop model provides a standardized, ISO 10993-4 compliant method to evaluate hemocompatibility of vascular medical devices under controlled flow conditions. By minimizing mechanical activation of blood components, the model enables reliable assessment of material-blood interactions critical for preclinical safety screening. It supports target validation and mechanistic de-risking by isolating device-specific effects from procedural artifacts, improving predictive confidence in early-stage device selection.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by isolating vascular device effects on blood coagulation and complement pathways.
- Operational Value: Provides reproducible quantification of hemolysis, leukocyte activation, and platelet aggregation under standardized shear conditions.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems (human blood) for downstream compound or device screening workflows.
- Operational Value: Ensures assay standardization through precise loop closure, controlled rotation, and consistent sample handling.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant system modeling by testing device interactions with human whole blood under physiological temperature.
- Operational Value: Facilitates translational biomarker analysis via flow cytometric detection of monocyte-platelet aggregates and leukocyte integrin status.
Pipeline & Workflow Integration
The model fits within the discovery-to-preclinical continuum, enabling early hemocompatibility screening before lead identification and supporting go/no-go decisions based on blood-material interaction profiles.
- Discovery Biology: Supports hypothesis testing by measuring device-induced changes in fibrinopeptide A, sC5b-9, and cytokine release as mechanistic readouts.
- Screening: Delivers quantitative outputs (free plasma hemoglobin, cell counts, activation markers) for comparing device coatings or materials.
- Analytics: Enables statistical comparison of coagulation, complement, and leukocyte activation across test conditions.
- Translational Research: Connects to preclinical continuity through analysis of host cell activation markers relevant to thrombosis and inflammation.
- Enterprise Reuse: Establishes a reusable platform for iterative device design evaluation across multiple projects.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by distinguishing material effects from activation due to improper assembly or handling.
- Operational Value: Ensures reproducibility through standardized loop closure, heparinized blood preparation, and fixed rotation parameters.
- Strategic Value: Improves go/no-go decisions by providing early hemocompatibility profiles that predict thrombotic or inflammatory risks.
- Portfolio Impact: Enables risk-adjusted prioritization of vascular devices based on complement, coagulation, and leukocyte activation thresholds.
Implementation Considerations
- Requires expertise in hemodynamics, blood handling, and flow cytometry to avoid pre-analytical artifacts.
- Depends on precision instrumentation including loop cradles, rotation units, and imaging systems for splice validation.
- Necessitates cross-team standardization of blood collection, heparin dosing, and loop sealing procedures.
- Involves adaptation considerations when testing devices of varying geometry or surface properties within the loop system.
- Limited by the need for meticulous loop closure to prevent thrombus formation at splices, which can confound results.
Biopharma FAQs
Why does proper loop closure matter for hemocompatibility testing?
Inaccurate loop closure creates gaps that lead to thrombus formation, activating coagulation and platelet pathways and confounding device-specific blood interactions.
How does isolating independent variables improve target validation in vascular device screening?
By controlling mechanical forces through standardized rotation and loop design, the model isolates material-specific effects on blood components, enabling clear attribution of activation to the test device.
What quantitative dependent variable measurements enable mechanistic de-risking?
Measurements of free plasma hemoglobin, fibrinopeptide A, sC5b-9, and leukocyte activation markers (PMN elastase, TNF, IL-6) provide quantitative endpoints to assess coagulation, complement, and inflammatory pathways.
Why are replication requirements critical for cross-functional collaboration in device development?
Replication ensures consistent hemocompatibility profiles across testing sites, allowing toxicology, formulation, and clinical teams to rely on reproducible data for go/no-go decisions.
What statistical analysis capabilities are required before implementing this model in preclinical workflows?
The model requires comparison of activation markers across multiple device conditions using appropriate statistical tests to determine significant differences in hemocompatibility outcomes.
Chapters in this video
0:04
Introduction
0:43
In Vitro Hemodynamic Loop Assembly and Blood Collection
2:59
Blood Sample Processing and Scanning Electron Microscopy (SEM) and Microcomputed Tomography (CT) Imaging Preparation
4:16
Flow Cytometry
6:12
Results: Representative Hemocytocompatibility and Host Cell Activation Analyses
8:09
Conclusion
![Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F54014.jpg%3Fv%3D2026-08-26T10%253A21%253A11.000Z&w=384&q=75)
